Cargando…
Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial
After treatment with local excision for TNM stage I low rectal cancer, the risk of local recurrence is not only high for T2 lesions but also for T1 lesions with features of massive invasion to the submucosal layer and/or lymphovascular invasion. OBJECTIVE: The purpose of this study was to determine...
Autores principales: | Sasaki, Takeshi, Ito, Yoshinori, Ohue, Masayuki, Kanemitsu, Yukihide, Kobatake, Takaya, Ito, Masaaki, Moriya, Yoshihiro, Saito, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553237/ https://www.ncbi.nlm.nih.gov/pubmed/28796729 http://dx.doi.org/10.1097/DCR.0000000000000870 |
Ejemplares similares
-
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212
por: Katsumata, Kenji, et al.
Publicado: (2021) -
Protocol for a single-arm confirmatory trial of adjuvant chemoradiation for patients with high-risk rectal submucosal invasive cancer after local resection: Japan Clinical Oncology Group Study JCOG1612 (RESCUE study)
por: Kadota, Tomohiro, et al.
Publicado: (2020) -
A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study)
por: Ohue, Masayuki, et al.
Publicado: (2017) -
Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)
por: Ohue, Masayuki, et al.
Publicado: (2021) -
Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial
por: Noguchi, Masaaki, et al.
Publicado: (2021)